Keywords: sex differences, GLP-1, exendin-4, semaglutide, estrogens, obesity Despite ample evidence for sex differences in the action of key metabolic hormones and established actions of gonadal steroids on ingestive and motivated behaviors, preclinical studies still do not consistently test female subjects, and when they do, they often fail to show sex-disaggregated data
While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments
Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity
Modulation of glutathione and its related enzymes in plants responses to toxic metals and metalloidsA review